SGLT2 Inhibitors Improve Cardiovascular Outcomes Across Groups

A comprehensive meta-analysis finds cardiovascular improvement across age, sex, and race/ethnicity for high-risk individuals with type 2 diabetes and other CVD risk factors.

Related Keywords

Illinois ,United States ,Southern Illinois University ,Springfield ,Mukul Bhattarai ,Southern Illinois University School Of Medicine , ,Southern Illinois University School ,Consistent Cardiovascular Benefits ,Seen Across Age ,Ethnicity Subgroups ,Heart Failure ,Sglt2 Inhibitors ,Odium Glucose Transporter 2 Inhibitors ,Odium Glucose Co Transporter 2 Inhibitors ,Sodium Glucose Cotransporter 2 Inhibitors ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Ami ,Acute Myocardial Infarction ,Myocardial Infarction ,Acute Coronary Syndrome Acs ,Cute Coronary Syndrome ,Cs ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovasc ,